IFNL3, interferon lambda 3, 282617

N. diseases: 175; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Polymorphisms of inosine triphosphate pyrophosphatase (rs1127354 and rs6051702) and interferon lambda 4 (IFLN4) (rs12979860) are indicators of anemia and/or sustained virological response (SVR) in patients with chronic hepatitis C on ribavirin/interferon. 31359493 2020
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C. 29893697 2019
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE The interleukin 28B gene polymorphism, rs8099917, in patients with chronic hepatitis C and response to the treatment with pegylated interferon and ribavirin. 30988680 2019
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 Biomarker disease BEFREE Interferon lambda 3 (IFN-λ3) is associated with liver fibrosis and inflammation in chronic hepatitis C (CHC) patients, but its impact on carcinogenesis remains controversial and little is known about its effects after viral clearance. 30623518 2019
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis C. 29399747 2018
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Reports of the role of host interleukin 28B (IL-28B) genetic variants in liver disease severity in patients with chronic hepatitis C (CHC) have obtained conflicting results. 29517696 2018
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Recent genomewide association studies in chronic hepatitis C have found a strong influence of genetic polymorphism near the IL28B (IFNL3) gene in response to IFN-α treatment. 29369421 2018
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 Biomarker disease BEFREE Data Mining and Machine Learning Algorithms Using IL28B Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C. 29279441 2018
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele. 28903504 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE The interdependence and roles of T cell-mediated immune responses and IL28B rs12979860 single-nucleotide polymorphism genotype as predictors of virological response to anti-HCV treatment in patients with chronic hepatitis C were evaluated using nonparametric tests. 28440692 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients. 28214926 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C. 28703131 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Moreover, IFNα is used in the therapy of chronic hepatitis C, where a single nucleotide polymorphism of interleukin-28B gene (IL28B) correlates with therapy response. 28214980 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C. 28579527 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE A comparative study of various methods for detection of IL28B rs12979860 in chronic hepatitis C. 28281380 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 Biomarker disease BEFREE Single nucleotide polymorphisms (SNPs) within DNA region containing interferon lambda 3 (IFNL3) and IFNL4 genes are prognostic factors of treatment response in chronic hepatitis C (CHC). 27125837 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Distribution of polymorphisms rs12979860, rs8099917 and rs12980275 IL28B in patients with chronic hepatitis C. 29264884 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C. 27714501 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C. 28797039 2017
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE No long-term data have been published on the durability of response following pegylated interferon (PegIFN) treatment in children with chronic hepatitis C. This prospective, multicenter, long-term follow-up (LTFU) study aimed to assess long-term durability of sustained virological response (SVR), long-term safety and tolerability, and the association between IL28B genotype and treatment response, in children previously treated with PegIFN alfa-2a ± ribavirin (RBV) in the PEDS-C trial. 26284539 2016
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C. 27751759 2016
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Type I IFNs (IFNA1, IFNB1), type II (IFNG), type III (IFNL1, IFNL2/3), IFNL4 and ISG hepatic expressions were measured by qPCR from in 65 chronic hepatitis C (CHC) patients whose IFNL4-associated rs368234815 and IFNL3-associated rs12989760 genotype were determined. 26020282 2016
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE IL28B SNP rs12979860 is the Critical Predictor for Sustained Viral Response in Chinese Children Aged 1 to 6 Years with Chronic Hepatitis C. 27877087 2016
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis. 25918016 2016
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.200 GeneticVariation disease BEFREE Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C. 26911666 2016